Literature DB >> 26060453

Cancer of the esophagus: histopathological sub-types in northern Uganda.

O N Alema1, B Iva1.   

Abstract

BACKGROUND: Esophageal cancer is the eighth most common cause of cancer death worldwide with squamous cell carcinoma and adenocarcinoma carcinoma as the main histopathological subtypes. Esophageal cancer is known for its marked variation by geographic region, ethnicity, and gender. Hitherto, the histopathological subtype of this cancer in Northern Uganda were not known. Therefore the aim of the study was to describe the characteristics of esophageal cancer with respect to the histopathologic subtypes, different sites of occurrence, age and gender in this region since its distribution varies with location.
METHODS: The study was carried out at Lacor Hospital, in northern part of Uganda. The record of 71 patients who had endoscopic and histopathological diagnosis of cancer of esophagus over a period of 3 years between January 2009 and December 2011 were retrospectively analyzed.
RESULTS: A total of 140 patients had endoscopic diagnosis of cancer of the esophagus and of these, 71 patients had both endoscopic and histopathological diagnosis of cancer of esophagus during the three-year period covered in the study between January 2009 to December 2011. The female to male ratio was 1:3 with mean age of 55.5 years ± SD 11.8. The common histopathological pattern of cancer of esophagus was squamous cell carcinoma of esophageal consisting of 66 patients (93.o%). The ratio of squamous cell carcinoma to adenocarcinoma was 13:1.The majority of the esophageal cancers were found in the middle third with 38 patients (53.52%), followed by lower third with 27 patients (38.0%) and the upper third which was only 6 patients (8.5%). CONCLUSSIONS: Squamous cell carcinoma is the most common histopathological subtype in this geographical location with overall cancer of the esophagus mainly affecting the lower 2/3 of the esophagus with the majority in the middle third.

Entities:  

Keywords:  Uganda; cancer of esophagus; histopathological subtypes

Mesh:

Year:  2014        PMID: 26060453      PMCID: PMC4449046          DOI: 10.4314/ahs.v14i1.4

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  21 in total

1.  More evidence for the increasing prevalence of adenocarcinoma of the esophagus over an 18-year period.

Authors:  M Y Chen; D J Ott; D W Gelfand
Journal:  J Clin Gastroenterol       Date:  1995-10       Impact factor: 3.062

2.  Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors.

Authors:  L M Brown; R Hoover; D Silverman; D Baris; R Hayes; G M Swanson; J Schoenberg; R Greenberg; J Liff; A Schwartz; M Dosemeci; L Pottern; J F Fraumeni
Journal:  Am J Epidemiol       Date:  2001-01-15       Impact factor: 4.897

3.  Recent trends in the epidemiology of esophageal cancer. Comparison of epidermoid- and adenocarcinomas.

Authors:  T N Moyana; M Janoski
Journal:  Ann Clin Lab Sci       Date:  1996 Nov-Dec       Impact factor: 1.256

4.  Cancer of the esophagus in Central Africa.

Authors:  S Wapnick; L N Zanamwe; M Chitiyo; J M Mynors
Journal:  Chest       Date:  1972-06       Impact factor: 9.410

5.  Changing pattern of esophageal cancer incidence in New Mexico.

Authors:  K J Vega; M M Jamal
Journal:  Am J Gastroenterol       Date:  2000-09       Impact factor: 10.864

6.  Smoking and Cancer in Poland.

Authors:  J Staszewski
Journal:  Br J Cancer       Date:  1960-09       Impact factor: 7.640

7.  Oesophageal cancer: a common malignancy in young people of Bomet District, Kenya.

Authors:  Russell E White; Christian C Abnet; Caesar K Mungatana; Sanford M Dawsey
Journal:  Lancet       Date:  2002-08-10       Impact factor: 79.321

8.  Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935-89.

Authors:  T Zheng; S T Mayne; T R Holford; P Boyle; W Liu; Y Chen; M Mador; J Flannery
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

9.  Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use?

Authors:  L M Brown; R N Hoover; R S Greenberg; J B Schoenberg; A G Schwartz; G M Swanson; J M Liff; D T Silverman; R B Hayes; L M Pottern
Journal:  J Natl Cancer Inst       Date:  1994-09-07       Impact factor: 13.506

10.  The incidence of cancer of the oesophagus in West Kenya.

Authors:  N Ahmed; P Cook
Journal:  Br J Cancer       Date:  1969-06       Impact factor: 7.640

View more
  13 in total

1.  Non communicable diseases and infections refuse to go away despite current knowledge and scientific advances.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

Review 2.  Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors.

Authors:  V A McCormack; D Menya; M O Munishi; C Dzamalala; N Gasmelseed; M Leon Roux; M Assefa; O Osano; M Watts; A O Mwasamwaja; B T Mmbaga; G Murphy; C C Abnet; S M Dawsey; J Schüz
Journal:  Int J Cancer       Date:  2016-08-24       Impact factor: 7.396

3.  Population attributable fraction of Esophageal squamous cell carcinoma due to smoking and alcohol in Uganda.

Authors:  Samson Okello; Cristina Churchill; Rogers Owori; Benson Nasasira; Christine Tumuhimbise; Charles Lagoro Abonga; David Mutiibwa; David C Christiani; Kathleen E Corey
Journal:  BMC Cancer       Date:  2016-07-11       Impact factor: 4.430

4.  Systematic review and meta-analysis of esophageal cancer in Africa: Epidemiology, risk factors, management and outcomes.

Authors:  Akwi W Asombang; Nathaniel Chishinga; Alick Nkhoma; Jackson Chipaila; Bright Nsokolo; Martha Manda-Mapalo; Joao Filipe G Montiero; Lewis Banda; Kulwinder S Dua
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

5.  Oesophageal cancer magnitude and presentation in Ethiopia 2012-2017.

Authors:  Abigiya Wondimagegnehu; Selamawit Hirpa; Samson Wakuma Abaya; Muluken Gizaw; Sefonias Getachew; Wondimu Ayele; Robel Yirgu; Tamiru Demeke; Berhe Dessalegn; Jilcha Diribi; Mirgissa Kaba; Mathewos Assefa; Ahmedin Jemal; Eva Johanna Kantelhardt; Adamu Addissie
Journal:  PLoS One       Date:  2020-12-01       Impact factor: 3.240

6.  Clinico-Pathological Findings and Spatial Distributions of Esophageal Cancer in Arsi Zone, Oromia, Central Ethiopia.

Authors:  Haji Aman Deybasso; Kedir Teji Roba; Berhanu Nega; Tefera Belachew
Journal:  Cancer Manag Res       Date:  2021-03-23       Impact factor: 3.989

7.  Clinical, epidemiological, and diagnostic characteristics of esophageal carcinoma in a Pakistani population.

Authors:  Muhammad Sohaib Asghar; Noman Ahmed Khan; Syed Jawad Haider Kazmi; Maira Hassan; Uzma Rasheed; Rumael Jawed; Rabail Yaseen; Syed Anosh Ali Naqvi
Journal:  Ann Saudi Med       Date:  2021-04-01       Impact factor: 1.526

8.  Current Trends of Carcinoma: Experience of a Tertiary Care Cancer Center in North India.

Authors:  Manjit K Rana; Tushar S Barwal; Uttam Sharma; Richika Bansal; Karuna Singh; Amrit Pal S Rana; Aklank Jain; Utkarshni Khera
Journal:  Cureus       Date:  2021-06-21

9.  Esophageal cancer male to female incidence ratios in Africa: A systematic review and meta-analysis of geographic, time and age trends.

Authors:  Daniel R S Middleton; Liacine Bouaoun; Rachel Hanisch; Freddie Bray; Charles Dzamalala; Steady Chasimpha; Diana Menya; Charles Gombé Mbalawa; Guy N'Da; Mathewos A Woldegeorgis; Ramou Njie; Moussa Koulibaly; Nathan Buziba; Josefo Ferro; Hassan Nouhou; Femi Ogunbiyi; Henry R Wabinga; Eric Chokunonga; Margaret Z Borok; Anne R Korir; Amos O Mwasamwaja; Blandina T Mmbaga; Joachim Schüz; Valerie A McCormack
Journal:  Cancer Epidemiol       Date:  2018-02-06       Impact factor: 2.984

10.  Prevalence of aflatoxin, ochratoxin and deoxynivalenol in cereal grains in northern Uganda: Implication for food safety and health.

Authors:  Richard Echodu; Geoffrey Maxwell Malinga; Joyce Moriku Kaducu; Emilio Ovuga; Geert Haesaert
Journal:  Toxicol Rep       Date:  2019-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.